Variant report

Variant	nsv970320
Chromosome Location	chr6:160696706-160707570
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:28)
CpG islands
(count:122)
Chromatin interactive
region (count:1)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:28 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr6:160696661-160696994	HepG2	liver:	n/a	n/a
2	CEBPB	chr6:160696689-160696941	K562	blood:	n/a	n/a
3	CEBPB	chr6:160696618-160697037	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr6:160696889-160696918	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTCF	chr6:160700660-160700810	NHEK	skin:	n/a	n/a
6	CTCF	chr6:160699440-160699590	HepG2	liver:	n/a	n/a
7	CTCF	chr6:160702051-160702153	Kidney_OC	kidney:	n/a	n/a
8	CUX1	chr6:160703536-160703812	K562	blood:	n/a	n/a
9	E2F4	chr6:160697599-160697782	MCF10A-Er-Src	breast:	n/a	n/a
10	E2F4	chr6:160705837-160706037	MCF10A-Er-Src	breast:	n/a	n/a
11	FOS	chr6:160700947-160701147	MCF10A-Er-Src	breast:	n/a	n/a
12	FOS	chr6:160700937-160701186	MCF10A-Er-Src	breast:	n/a	n/a
13	FOS	chr6:160700881-160701234	MCF10A-Er-Src	breast:	n/a	n/a
14	FOS	chr6:160700857-160701219	MCF10A-Er-Src	breast:	n/a	n/a
15	FOSL2	chr6:160700869-160701221	A549	lung:	n/a	n/a
16	GATA3	chr6:160703832-160704147	SH-SY5Y	brain:	n/a	n/a
17	MAFK	chr6:160705820-160705827	H1-hESC	embryonic stem cell:	n/a	n/a
18	NR3C1	chr6:160699804-160700219	A549	lung:	n/a	n/a
19	NR3C1	chr6:160699891-160700142	A549	lung:	n/a	n/a
20	NR3C1	chr6:160699835-160700199	A549	lung:	n/a	n/a
21	NR3C1	chr6:160699822-160700315	A549	lung:	n/a	n/a
22	NR3C1	chr6:160699854-160700267	A549	lung:	n/a	n/a
23	SETDB1	chr6:160700898-160701441	U2OS	brain:	n/a	n/a
24	STAT3	chr6:160700920-160701008	MCF10A-Er-Src	breast:	n/a	n/a
25	STAT3	chr6:160700952-160700966	MCF10A-Er-Src	breast:	n/a	n/a
26	STAT3	chr6:160702330-160702629	MCF10A-Er-Src	breast:	n/a	n/a
27	ZNF143	chr6:160698623-160698778	H1-hESC	embryonic stem cell:	n/a	n/a
28	ZNF143	chr6:160696770-160697025	H1-hESC	embryonic stem cell:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:160697625-160697675	NHDF-neo	bronchial:	n/a
2	chr6:160696810-160696860	NT2-D1	testis:	n/a
3	chr6:160696810-160696860	PANC-1	pancreas:	n/a
4	chr6:160697625-160697675	CMK	blood:	n/a
5	chr6:160697625-160697675	ovcar-3	ovarian:	n/a
6	chr6:160696810-160696860	A549	lung:	n/a
7	chr6:160697625-160697675	RPTEC	kidney:	n/a
8	chr6:160696810-160696860	HPAEpiC	pulmonary alveolar:	n/a
9	chr6:160696810-160696860	ECC-1	luminal epithelium:	n/a
10	chr6:160697625-160697675	HRCEpiC	kidney:	n/a
11	chr6:160696810-160696860	HCT-116	colon:	n/a
12	chr6:160697625-160697675	HRE	kidney:	n/a
13	chr6:160697625-160697675	HIPEpiC	eye:	n/a
14	chr6:160697625-160697675	SAEC	small airway:	n/a
15	chr6:160696810-160696860	GM12891	blood:	n/a
16	chr6:160696810-160696860	NHBE	bronchial:	n/a
17	chr6:160696810-160696860	IMR90	lung:	fetal
18	chr6:160696810-160696860	HAEpiC	amniotic membrane:	n/a
19	chr6:160696810-160696860	LNCaP	prostate:	n/a
20	chr6:160696810-160696860	HCPEpiC	choroid plexus:	n/a
21	chr6:160696810-160696860	GM06990	blood:	n/a
22	chr6:160697625-160697675	SKMC	muscle:	n/a
23	chr6:160696810-160696860	AG04450	lung:	fetal
24	chr6:160696810-160696860	SK-N-MC	brain:	n/a
25	chr6:160696810-160696860	BE2_C	brain:	n/a
26	chr6:160697625-160697675	HEEpiC	esophagus:	n/a
27	chr6:160697625-160697675	NHBE	bronchial:	n/a
28	chr6:160697625-160697675	HEK293	kidney:	embryo
29	chr6:160696810-160696860	HIPEpiC	eye:	n/a
30	chr6:160696810-160696860	PrEC	prostate:	n/a
31	chr6:160696810-160696860	SAEC	small airway:	n/a
32	chr6:160696810-160696860	SK-N-SH_RA	brain:	n/a
33	chr6:160697625-160697675	Hela-S3	cervix:	n/a
34	chr6:160697625-160697675	AoSMC	blood vessel:	n/a
35	chr6:160696810-160696860	HMEC	breast:	n/a
36	chr6:160697625-160697675	ECC-1	luminal epithelium:	n/a
37	chr6:160696810-160696860	MCF10A-Er-Src	breast:	n/a
38	chr6:160697625-160697675	LNCaP	prostate:	n/a
39	chr6:160696810-160696860	HCF	heart:	n/a
40	chr6:160697625-160697675	HRPEpiC	eye:	n/a
41	chr6:160697625-160697675	ProgFib	skin:	n/a
42	chr6:160696810-160696860	NHDF-neo	bronchial:	n/a
43	chr6:160697625-160697675	AG09309	skin:	n/a
44	chr6:160697625-160697675	HCF	heart:	n/a
45	chr6:160697625-160697675	HNPCEpiC	eye:	n/a
46	chr6:160696810-160696860	HEEpiC	esophagus:	n/a
47	chr6:160696810-160696860	HNPCEpiC	eye:	n/a
48	chr6:160696810-160696860	GM12878	blood:	n/a
49	chr6:160697625-160697675	AG04449	skin:	fetal
50	chr6:160696810-160696860	GM19239	blood:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:160692844..160695658-chr6:160695903..160698267,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLC22A3-1	chr6:160696793-160697162	ENSG00000230234

No data

Variant related genes	Relation type
SLC22A2	TF binding region
SLC22A2	CpG island
ENSG00000230234	chromatin interactions

Extended variants
information (count: 326 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:326 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs139010364	chr6:160696712-160696713	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs537534669	chr6:160696713-160696714	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs182975673	chr6:160696739-160696740	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs574910748	chr6:160696743-160696744	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs141522552	chr6:160696766-160696767	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs564806741	chr6:160696790-160696791	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs560377964	chr6:160696799-160696800	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs577127753	chr6:160696808-160696809	Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
9	rs373515955	chr6:160696810-160696811	Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
10	rs662421	chr6:160696828-160696829	Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs113738481	chr6:160696829-160696830	Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
12	rs147045409	chr6:160696832-160696833	Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
13	rs570107951	chr6:160696849-160696850	Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
14	rs662301	chr6:160696919-160696920	Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs505000	chr6:160696934-160696935	Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs374511609	chr6:160696966-160696967	Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
17	rs529824066	chr6:160696967-160696968	Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
18	rs76827843	chr6:160697053-160697054	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
19	rs113432184	chr6:160697065-160697066	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
20	rs540926240	chr6:160697078-160697079	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
21	rs552545006	chr6:160697084-160697085	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
22	rs568744850	chr6:160697095-160697096	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
23	rs537872610	chr6:160697104-160697105	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
24	rs377377510	chr6:160697132-160697133	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
25	rs554336935	chr6:160697136-160697137	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
26	rs574489590	chr6:160697164-160697165	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs534084765	chr6:160697199-160697200	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs2297213	chr6:160697208-160697209	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs531058827	chr6:160697209-160697210	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs554398720	chr6:160697211-160697212	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs115826818	chr6:160697228-160697229	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs546082148	chr6:160697238-160697239	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs574404559	chr6:160697251-160697252	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs543571834	chr6:160697252-160697253	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs576337817	chr6:160697292-160697293	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs316036	chr6:160697306-160697307	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs562008050	chr6:160697309-160697310	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs187609582	chr6:160697324-160697325	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs2297212	chr6:160697325-160697326	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs113078293	chr6:160697328-160697329	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs546940742	chr6:160697345-160697346	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs369123117	chr6:160697405-160697406	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs191023278	chr6:160697427-160697428	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs183540784	chr6:160697457-160697458	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs375161746	chr6:160697478-160697479	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs569152323	chr6:160697488-160697489	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs138042398	chr6:160697517-160697518	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs57187107	chr6:160697604-160697605	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs548175754	chr6:160697620-160697621	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs368318859	chr6:160697626-160697627	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Malignant melanoma	17260012	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Soft tissue tumor	16732325	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17850661	CNVD
Renal cell carcinoma	18765545	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Breast cancer	20556506	CNVD
Hirschsprung''s Disease	21712996	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Developmental delay	19459884	CNVD
Hearing loss	19459884	CNVD
Microcephaly	19459884	CNVD
Coronary artery disease	17160897	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:46 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:160694600-160696800	Weak transcription	Psoas Muscle	Psoas
2	chr6:160695400-160697000	Enhancers	Skeletal Muscle Male	skeletal muscle
3	chr6:160695800-160696800	Weak transcription	Brain Anterior Caudate	brain
4	chr6:160695800-160697000	Flanking Active TSS	Liver	Liver
5	chr6:160695800-160698800	Enhancers	Fetal Muscle Leg	muscle
6	chr6:160696400-160696800	Enhancers	Brain Germinal Matrix	brain
7	chr6:160696400-160697000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
8	chr6:160696400-160697000	Enhancers	Pancreas	Pancrea
9	chr6:160696400-160697000	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
10	chr6:160696600-160697000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr6:160696600-160698800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr6:160696800-160697200	Enhancers	Brain Anterior Caudate	brain
13	chr6:160696800-160697200	Enhancers	Placenta	Placenta
14	chr6:160696800-160697400	Enhancers	Brain Substantia Nigra	brain
15	chr6:160696800-160697600	Enhancers	H1 Cell Line	embryonic stem cell
16	chr6:160696800-160698600	Enhancers	Psoas Muscle	Psoas
17	chr6:160697000-160697200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
18	chr6:160697000-160697200	Enhancers	Liver	Liver
19	chr6:160697000-160698400	Enhancers	Skeletal Muscle Female	skeletal muscle
20	chr6:160697000-160698600	Weak transcription	Gastric	stomach
21	chr6:160697000-160698800	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
22	chr6:160697000-160699000	Enhancers	Fetal Muscle Trunk	muscle
23	chr6:160697600-160700000	Weak transcription	H1 Cell Line	embryonic stem cell
24	chr6:160698200-160699200	Enhancers	Fetal Brain Male	brain
25	chr6:160698400-160698800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
26	chr6:160698400-160698800	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
27	chr6:160698600-160700000	Weak transcription	Psoas Muscle	Psoas
28	chr6:160698800-160699600	Enhancers	Skeletal Muscle Male	skeletal muscle
29	chr6:160698800-160699600	Enhancers	Skeletal Muscle Female	skeletal muscle
30	chr6:160698800-160699800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr6:160699600-160700400	Enhancers	NHEK	skin
32	chr6:160699800-160700000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr6:160699800-160701200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
34	chr6:160700000-160700200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
35	chr6:160700000-160700400	Enhancers	H1 Cell Line	embryonic stem cell
36	chr6:160700000-160700400	Enhancers	HUES6 Cell Line	embryonic stem cell
37	chr6:160700200-160700400	Enhancers	Psoas Muscle	Psoas
38	chr6:160700200-160700800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
39	chr6:160700200-160700800	Enhancers	HMEC	breast
40	chr6:160700400-160700800	Flanking Active TSS	NHEK	skin
41	chr6:160700800-160701400	Enhancers	NHEK	skin
42	chr6:160705400-160706200	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
43	chr6:160706200-160707600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr6:160706400-160707600	Enhancers	Stomach Mucosa	stomach
45	chr6:160707000-160707600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
46	chr6:160707400-160707800	Enhancers	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links